4.3 Review

Technetium-99m metastable radiochemistry for pharmaceutical applications: old chemistry for new products

Journal

JOURNAL OF COORDINATION CHEMISTRY
Volume 72, Issue 11, Pages 1759-1784

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/00958972.2019.1632838

Keywords

Nuclear medicine; radiopharmacy; radiochemistry; radiopharmaceuticals; chemistry

Funding

  1. National Scientific and Technological Research Council (CNPQ)
  2. Rio de Janeiro State Research Foundation (FAPERJ)
  3. CAPES

Ask authors/readers for more resources

Radiopharmacy is a pharmaceutical specialty responsible for the development and production of radiopharmaceuticals. Radiopharmaceuticals are radioactive drugs, which can be used in two distinct manners: first for diagnosis in oncological, neurological and cardiac diseases, and second for therapy in oncology. Given their great specificity and precision, radiopharmaceuticals are among the most technological products in the field of pharmacy. Among radiopharmaceuticals, radiopharmaceuticals based on Tc-99m are the most widely used in the world. However, radiopharmacy and radiopharmaceuticals are still restricted to a few research centers in the world today. This is largely due to the difficulty in obtaining the radioactive material, the precursor of the radiopharmaceutical, as well as the understanding of the chemistry involved in these materials. In this sense, this study addresses the radiochemistry of radiopharmaceuticals based on Tc-99m as well as the coordination chemistry of these compounds. Finally, this review addresses the pharmaceutical aspects of Tc-99m radiopharmaceuticals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available